News View all news
Marijuana use in CV patients can be risky, review shows
A recent comprehensive review published in the January 28 issue of the Journal of the American College of Cardiology (JACC) highlights cardiovascular (CV) considerations related to marijuana use, pharmacological interactions, and clinical implications for use of cannabis in patients with CV disease. Pharmacists should be aware of which of their patients are currently using cannabis products and the potential for CV adverse effects and drug–drug interactions.
Authors retract studies that found risks of using antimalaria drugs against COVID-19
Two major studies casting doubt on the ability of antimalaria drugs to treat COVID-19 patients were retracted Thursday by the scientific journals in which they had appeared, The New England Journal of Medicine and The Lancet, because the authors could not verify the data on which the results depended.
Top medical journals raise concerns about data in two studies related to COVID-19
Just days after more than 180 scientists raised questions about the statistical analysis and a lack of transparency in a hydroxychloroquine study in The Lancet, the researchers say they have "similar issues" with a recent New England Journal of Medicine study about the safety of heart drugs in COVID-19.
APhA swears in Scott Knoer as CEO
Scott Knoer, MS, PharmD, FASHP, was sworn in Monday as chief executive officer and executive vice president of APhA. "Being sworn in as the leader of this storied organization is the greatest honor of my life," Knoer said during a virtual ceremony witnessed by APhA members and staff.
June 2, 2020
The biggest challenge of our lives
Yesterday was my first official day as executive vice president and CEO of APhA, and I planned to write a blog introducing myself and establishing my goals for the association. Plans don’t mean much…0 comments
June 5, 2020
National Pharmacy Organizations Unite to Take a Stand Against Racial Injustice
The National Pharmaceutical Association and 13 national pharmacy associations have issued a joint statement in support of the ongoing fight against racism and discrimination.
June 1, 2020
APhA Swears in Scott J. Knoer as its 13th Chief Executive Officer
Scott J. Knoer, MS, PharmD, FASHP, was sworn in today as the 13th Chief Executive Officer and Executive Vice President of the American Pharmacists Association, during a virtual ceremony witnessed by APhA members and staff.
APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.